2016
DOI: 10.1097/rlu.0000000000000982
|View full text |Cite
|
Sign up to set email alerts
|

Neurolymphomatosis on 18F-FDG PET/CT

Abstract: Neurolymphomatosis represents a peripheral lymphomatous neural infiltration and is a relatively rare condition. Histopathologically, most patients are demonstrated to have non-Hodgkin lymphoma. A 27-year-old man with a history of HLA-B27-positive ankylosing spondylitis and diffuse large B-cell lymphoma was referred for the investigation of a severe neuropathic pain radiating down his right hip and posterior thigh for 1 month. This report describes the diagnosis and therapy response assessment in a relapsing ag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Targeted MRI neurography at sites of hypermetabolism can be expected to substantially further improve the anatomical characterization of intraneural invasion. In addition, 18 FDG-PET has been demonstrated to be helpful in monitoring the response to therapy [30, 31].…”
Section: Discussionmentioning
confidence: 99%
“…Targeted MRI neurography at sites of hypermetabolism can be expected to substantially further improve the anatomical characterization of intraneural invasion. In addition, 18 FDG-PET has been demonstrated to be helpful in monitoring the response to therapy [30, 31].…”
Section: Discussionmentioning
confidence: 99%
“…18 Several studies demonstrate the usefulness of 18 F-FDG PET in response assessment of NL after chemotherapy. 19,20 Conclusions 18 F-FDG PET-CT is a sensitive imaging modality for the detection of neurolymphomatosis lesions. It helps in the initial diagnosis, staging, guiding biopsy, treatment planning, response assessment, and prognostication of the disease.…”
Section: Magnetic Resonance Imaging (Mri)mentioning
confidence: 99%